PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1984 | 1 |
| 1991 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 8 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 7 |
| 2008 | 13 |
| 2009 | 18 |
| 2010 | 28 |
| 2011 | 39 |
| 2012 | 30 |
| 2013 | 43 |
| 2014 | 54 |
| 2015 | 70 |
| 2016 | 63 |
| 2017 | 47 |
| 2018 | 67 |
| 2019 | 71 |
| 2020 | 53 |
| 2021 | 57 |
| 2022 | 71 |
| 2023 | 46 |
| 2024 | 24 |
| 2025 | 84 |
| 2026 | 49 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"J Pathol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Comprehensive genomic profiling of mucosal melanoma reveals novel fusion transcripts and dysregulation of cell-cycle, MAPK, and PI3K pathways.
- Monti M, Romanello MB, Agnelli L, Orlandi M, Bertoli L, Picinoli S, Pezzali I, Mandelli GE, Medicina D, Ribaudo G, Busico A, Conca E, Pellegrini V, Balzarini P, Gallucci D, Di Matteo A, Lombardi D, Ghigna C, Pruneri G, Gianoncelli A, Rossato M, Vermi W.
- J Pathol. 2026 Aug 31;270(3):380-395. doi: 10.1002/path.70108.
- PMCID: PMC13635605
Monti M, et al.J Pathol. 2026.PMCID: PMC13635605 -
CCL5 and GLUT1 define leader cells in collective invasion of colorectal cancer.
- Zhang Z, Tan J, Zeng Z, Zhu X, Mai L, Yin Y, Huang Y, Kang W, Jiang H, Xu S, Ding Y, Pan X, Wang F, Liang L.
- J Pathol. 2026 Aug 12;270(3):288-302. doi: 10.1002/path.70100.
- PMCID: PMC13635607
Zhang Z, et al.J Pathol. 2026.PMCID: PMC13635607 -
Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.
- De Leo A, Wickenberg M, Grillini M, Coadǎ CA, Praveen Kumar P, Tong A, Key J, Kim H, Kommoss F, Carey M, Fu Y, Ceccarelli C, Tallini G, LaPointe P, Köbel M, Lee CH.
- J Pathol. 2026 Jul 31;270(3):317-327. doi: 10.1002/path.70102.
- PMCID: PMC13635600
De Leo A, et al.J Pathol. 2026.PMCID: PMC13635600 -
Practical considerations for pathologists when selecting digital pathology systems: an ESDIP guide.
- Montezuma D, L'Imperio V, Ameisen D, Carvalho R, Boor P, Oliveira SP, Khalili N, Zlobec I, Zerbe N, Temprana-Salvador J.
- J Pathol. 2026 Jul 31;270(3):328-341. doi: 10.1002/path.70103.
- PMCID: PMC13635609
Montezuma D, et al.J Pathol. 2026.PMCID: PMC13635609 -
Optical genome mapping enhanced by refined variant interpretation in pediatric acute lymphoblastic leukemia.
- Bekő A, Péterffy B, Hughes A, Jakab JS, Haltrich I, Árvai KB, Bedics G, Csonka K, Papp G, Kapczár D, Bohusné Barta BA, Hegyi LL, Szalóki G, Barna G, Matolcsy A, Egyed B, Hevessy Z, Benard-Slagter A, Palit S, Savola S, Bödör C, Alpár D.
- J Pathol. 2026 Aug 5;270(2):241-254. doi: 10.1002/path.70096.
- PMCID: PMC13576893
Bekő A, et al.J Pathol. 2026.PMCID: PMC13576893 -
Diversified cell origin of Helicobacter pylori eradication-responsive gastric diffuse large B-cell lymphomas.
- Kuo SH, Yeh KH, Lin CW, Chen LT, Liou JM, Shun CT, Lee HW, Wei MF, Wang HP, Wu MS, Cheng AL.
- J Pathol. 2026 Aug 5;270(2):174-193. doi: 10.1002/path.70091.
- PMCID: PMC13576759
Kuo SH, et al.J Pathol. 2026.PMCID: PMC13576759 -
Exosomal lncRNA PVT1 promotes fibroblast activation and colon cancer progression via miR-23b-5p signaling.
- You L, Liu Z, Zhang B, Li J, Huang Y.
- J Pathol. 2026 Jul 31;270(2):255-268. doi: 10.1002/path.70098.
- PMCID: PMC13576819
You L, et al.J Pathol. 2026.PMCID: PMC13576819 -
Functional validation of driver mutation-specific uveal melanoma biomarkers: role of COL9A3 in cancer cell plasticity.
- van den Bosch Q, Verdijk RM, Fadlelseed H, van den Bosch T, Owens S, Kennedy S, Kilic E, Brosens E.
- J Pathol. 2026 Jul 21;270(2):226-240. doi: 10.1002/path.70094.
- PMCID: PMC13576891
van den Bosch Q, et al.J Pathol. 2026.PMCID: PMC13576891 -
Applying flow cytometry-based isolation of platelet-derived microparticles to banked human plasma for cellular studies.
- Fattahi N, Tyagi T, Kirlin F, Flores AL, Hwa J, Iwakiri Y, McConnell MJ.
- J Pathol. 2026 Jul 14;270(2):131-138. doi: 10.1002/path.70097.
- PMCID: PMC13576798
Fattahi N, et al.J Pathol. 2026.PMCID: PMC13576798 -
Immune dysregulation in the prostates of C57BL/6Aire-/- mice mirrors that seen in human benign prostatic hyperplasia.
- Lanman NA, Broman MM, Kothandaraman H, Cresswell GM, Awdalkreem GD, Wusiman D, Kolliegbo AK, Glaser AP, Helfand BT, Vickman RE, Yang J, Hayward SW, Ratliff TL.
- J Pathol. 2026 Jul 8;270(2):211-225. doi: 10.1002/path.70093.
- PMCID: PMC13576882
Lanman NA, et al.J Pathol. 2026.PMCID: PMC13576882